Please assess the completion status of the following clinical trial:

Trial Title: Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of nonmyeloid malignancy~* Moderate to severe anemia~* Adequate iron stores as measured by either TSAT or ferritin~* About to start cycle of chemotherapy~* Eligible for epoetin alfa therapy~Exclusion Criteria:~* Highly elevated TSAT or ferritin~* Recent transfusion, epoetin alfa, darbepoetin or intravenous iron~* Medical conditions that would confound the efficacy evaluation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).